Publications by authors named "Channing Paller"

Claim this Profile
N
National Cancer Institute's Working Group on Biochemically Recurrent Prostate Cancer: Clinical Trial Design Considerations.
David J Einstein, Melissa L Abel, Jeanny B Aragon-Ching, Philip M Arlen, Karen A Autio, Channing J Paller

J Clin Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Ga]Ga-PSMA-11 PET Tumor Volume Predicts Overall Survival of Patients with Metastatic Prostate Cancer Undergoing Taxane-Based Chemotherapy.
Stephan Beintner-Skawran, Andrei Gafita, Theo Lorenzini, Robert Tauber, Sebastian Hoberück, Channing J Paller

J Nucl Med· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Magnetic Resonance Imaging or Confirmatory Biopsy for Patients With Prostate Cancer Receiving Active Surveillance.
Matthew R Cooperberg, John R Bihn, John M Culnan, Jennifer La, Sergey D Goryachev, Channing J Paller

JAMA Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-Reported Outcomes From Males Regarding Germline Testing for Prostate Cancer: Results From the PROGRESS Registry.
Stacy Loeb, Scott W Keith, Laura Gross, Rebecca L Hartman, Tomasz M Beer, Channing J Paller

JCO Precis Oncol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Automated Extraction of Imaging and Pathology Data From Diverse Prostate Cancer Electronic Records.
John M Culnan, Sergey D Goryachev, John R Bihn, Grace Lee, Daniel C R Chen, Channing J Paller

JCO Clin Cancer Inform· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evidence-Based Clinical Protocols to Monitor Efficacy of [Lu]Lu-PSMA Radiopharmaceutical Therapy in Metastatic Castration-Resistant Prostate Cancer Using Real-World Data.
Lena M Unterrainer, Nicolas De Leiris, Marcus Unterrainer, Astrid Delker, Linus Hempel, Channing J Paller

J Nucl Med· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editorial: AI in digital oncology: imaging and wearable technology for cancer detection and management.
Souptik Barua, Channing J Paller, Navkiran Randhawa, Arvind Rao

Front Artif Intell· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implementation of Universal Germline Genetic Testing Into Standard of Care for Patients With Prostate Cancer: The Time Is Now.
Neal Shore, Sarah M Nielsen, Edward D Esplin, Emmanuel S Antonarakis, Pedro C Barata, Channing J Paller

JCO Oncol Pract· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of Radium-223 and Stereotactic Ablative Radiotherapy Versus Stereotactic Ablative Radiotherapy for Oligometastatic Prostate Cancers: The RAVENS Phase II Randomized Trial.
Jarey H Wang, Alexander D Sherry, Soha Bazyar, Philip Sutera, Noura Radwan, Channing J Paller

J Clin Oncol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implementing and Optimizing Universal Germline Genetic Testing for Patients With Prostate Cancer in Clinical Practice.
Neal Shore, Andrew J Armstrong, Pedro Barata, Lindsey Byrne, Jason Hafron, Channing Paller

Urology· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrating Botanicals into Oncology Care: Consideration of FDA Regulation of Botanical Products and Botanical Clinical Trials.
Tara A Berman, Eran Ben-Arye, Gunver S Kienle, Viraj Master, Alissa Huston, Channing J Paller

Clin Cancer Res· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Harnessing nature's therapeutic potential: A review of natural products in prostate cancer management.
Nicole A Metri, Adel Mandl, Channing J Paller

Urol Oncol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of hypoxia and iron on ascorbic acid-mediated cytotoxicity in prostate cancer cell lines.
Samiksha Deme, Ida Ramezani, Jonathan Coulter, Channing Paller, Joseph Bressler

Toxicol Appl Pharmacol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inferred clonal hematopoiesis from tumor DNA sequencing among men with prostate cancer: correlation with somatic tumor alterations and outcomes.
Yasaman Iranmanesh, Noha Omar, Arya Rasouli, Alex Baras, Sergiu Pasca, Channing J Paller

Oncologist· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of SGLT2 Inhibitor Initiation and PSA Response in Prostate Cancer.
Etan R Aber, Michael A Carducci, Channing J Paller, Sam R Denmeade, Kelli Rourke

Prostate· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Research Network: JHCRN Infrastructure and Lessons Learned.
Rahul Kashyap, Gayane Yenokyan, Robert Joyner, Melissa Gerstenhaber, Mary Alderfer, Channing J Paller

Clin Transl Sci· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CRM1 regulates androgen receptor stability and impacts DNA repair pathways in prostate cancer, independent of the androgen receptor.
Rajendra Kumar, Janet Mendonca, Abhishek Shetty, Yuhan Yang, Olutosin Owoyemi, Channing J Paller

FASEB J· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intratumoral heterogeneity drives acquired therapy resistance in a patient with metastatic prostate cancer.
Dena P Rhinehart, Jiaying Lai, David E Sanin, Varsha Vakkala, Adrianna Mendes, Channing J Paller

NPJ Precis Oncol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Navigating the unseen peril: safeguarding medical imaging in the age of AI.
Alexandra Maertens, Steve Brykman, Thomas Hartung, Andrei Gafita, Harrison Bai, Channing Judith Paller

Front Artif Intell· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Initial Experience with [Lu]Lu-PSMA-617 After Regulatory Approval for Metastatic Castration-Resistant Prostate Cancer: Efficacy, Safety, and Outcome Prediction.
Andrei Gafita, Andrew Voter, Somya Shesadri, Avery Spitz, Catherine H Marshall, Channing J Paller

J Nucl Med· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Toxicity of [Lu]Lu-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer: Results from the U.S. Expanded-Access Program and Comparisons with Phase 3 VISION Data.
Vishnu Murthy, Andrew F Voter, Kathleen Nguyen, Martin Allen-Auerbach, Lucia Chen, Channing J Paller

J Nucl Med· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Abiraterone, Olaparib, or Abiraterone + Olaparib in First-Line Metastatic Castration-Resistant Prostate Cancer with DNA Repair Defects (BRCAAway).
Maha Hussain, Masha Kocherginsky, Neeraj Agarwal, Nabil Adra, Jingsong Zhang, Channing J Paller

Clin Cancer Res· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Olaparib Without Androgen Deprivation for High-Risk Biochemically Recurrent Prostate Cancer Following Prostatectomy: A Nonrandomized Controlled Trial.
Catherine H Marshall, Benjamin A Teply, Jiayun Lu, Lia Oliveira, Hao Wang, Channing J Paller

JAMA Oncol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advancing Integrative Oncology: The Society for Integrative Oncology Education Committee's Journey and Vision.
Ting Bao, Gabriel Lopez, Terri Crudup, Ana Maria Lopez, Channing J Paller

J Integr Complement Med· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Abiraterone or Enzalutamide for Patients With Metastatic Castration-Resistant Prostate Cancer.
Jennifer La, Lin Wang, June K Corrigan, Deborah Lang, Michelle H Lee, Channing J Paller

JAMA Netw Open· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis